International
E.U. Reg. Backs Lung Cancer Drug
EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.
EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.
The recommendation is based on the mid-stage data that showed Enhertu showed objective response rate of 49%.
The drug is already approved in the European Union as a treatment for patients with an advanced form of breast cancer.
30-Year-Old Man’s Charges Upgraded to Murder
Woman Ordered to Refund Ex-Husband Over $21K In Child Support
Caribbean Agency: Heatwaves Won’t Be As Intense
China Promises To Safeguard Its Own Interests
France Calls For Suspension Of Investment In U.S. After Tariffs
Wall Street Opens Sharply Lower After Trump Tariffs
-
Court3 days agoHaitian Man Accused of Sexually Abusing Stepdaughter Has Day In Court
-
Court2 days agoMan Accused of Killing Two Prisoners Preparing for First Murder Trial
-
Court3 days agoJury Convicts Man of Robbing Former Pinewood MP and Wife
-
Court17 hours agoWoman Ordered to Refund Ex-Husband Over $21K In Child Support
-
Court2 days agoMan Sentenced to 20 Years for Killing Girlfriend in 2023
-
Court17 hours ago30-Year-Old Man’s Charges Upgraded to Murder
-
International18 hours agoChina Promises To Safeguard Its Own Interests
-
International18 hours agoFrance Calls For Suspension Of Investment In U.S. After Tariffs